BON Stock Analysis: Buy, Sell, or Hold?
BON - Bon Natural Life Limited Class A Ordinary Shares
$1.67
0.02 (1.21%)
β²
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Jan 26, 2026
0d
Get Alerted When BON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π‘ BUY OPPORTUNITY: BON shows positive signals but monitor for confirmation. Moderate conviction.
π‘ BUY OPPORTUNITY: BON shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BON is currently trading at $1.67, which is considered fair relative to its 30-day fair value range of $1.59 to $1.72.
Technical Outlook: Technically, BON is in a downtrend. Immediate support is located at $1.61, while resistance sits at $1.74.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $77.50 (+4597.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BON is in a downtrend. Immediate support is located at $1.61, while resistance sits at $1.74.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $77.50 (+4597.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.59 -
$1.72
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4597.0% below Wall St target ($77.50)
Fair Price Analysis
30-Day Fair Range
$1.59 -
$1.72
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.61
Resistance Level
$1.74
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
2.35
Wall Street Target
$77.50
(+4597.0%)
Revenue Growth (YoY)
-21.9%
Earnings Growth (YoY)
-41.0%
Profit Margin
-10.7%
Last updated: January 30, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$505 | 63 BUY |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$386 | 61 BUY |
|
DD
Dupont De Nemours Inc |
STRONG BUY
20 analysts |
$49 | 65 BUY |
|
APD
Air Products and Chemica⦠|
BUY
24 analysts |
$294 | 66 BUY |
|
IFF
International Flavors & β¦ |
STRONG BUY
22 analysts |
$82 | 60 HOLD |
Advanced BON Option Strategies
Professional options setups generated by AI based on today's BON price and gamma walls.